CFTR and cystic fibrosis: A population-based study of more than 19,000 heterozygous CFTR mutant carriers and 99,000 healthy controls found that CF carriers were at an increased risk for 59 CF-related diagnostic conditions, including a 44% increased risk of GI cancers (colorectum, stomach and other GI organs) [38,39].